Corporate news to the archive c-LEcta continues its growth in 2020 and increases its EBITDA above average DENARASE is the most important growth driver with applications in gene and cell therapy as well as vaccine production Sales for 2020 to exceed the EUR 10 million...
July 28, 2020 | c-LEcta expands collaboration with specialty medical logistics provider World Courier
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development has started working with World Courier, an AmerisourceBergen company. With a presence in 50+ countries, World Courier is driven by a commitment to excellence, and provides customized solutions with global reach to increase access to care; making them a highly trusted specialty logistics company for c-LEcta’s customers in the pharmaceutical industry.
Corporate news to the archive c-LEcta grows significantly in fiscal year 2019, strong start in 2020 Significant revenue growth of 114% compared to 2018, EBITDA slightly positive Product business further expanded and organizational growth driven forward Following...
Ad hoc news
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.